Panorama
Inside the Gray Space of Digital Therapeutics
I recently attended the second DTxDM conference of the year, which was held on ...
What Do Facebook Ad Changes Mean for Medical Advertising?
Facebook is currently weathering crises on multiple fronts. Investor confidence is declining, user patience ...
Changing Roles in Pharma & Biotech Companies: CSMs Are the New CRAs
The rapidly evolving clinical trial paradigm is prompting altered expectations of the traditional Clinical ...
It’s Programmatic, Not Program Magic, Advertising
Something Eugene Lee, Executive Vice President, Managing Director at CMI, said earlier this month ...
Crafting Highly Effective Incentive Compensation Plans for Your Sales Force
A fair and rewarding incentive compensation plan is an essential component of any successful ...
The Impact of Express Scripts’ 2019 Formulary Exclusion List
Earlier this month, Express Scripts announced its 2019 National Preferred Formulary (NPF), which added ...
What the “Healthcare Consumerism” Movement Means for Marketers
Between 2010 and 2014, the proportion of U.S. residents under the age of 65 ...
The Muscular Dystrophy Association Launches Expanded Patient Data Hub Initiative
The Muscular Dystrophy Association (MDA) has been building a longitudinal provider-entered registry of neuromuscular ...
Maximizing the Probability of Trial Success for CAR-T Cell Therapies
CAR-T cells are complex products, and translating them from basic and preclinical research to ...
4 Innovative Trials Types That Can Improve Drug Development Success
Innovation is revolutionizing a number of industries, but its impact has not yet been ...
The Unwritten Rules for Patient Advocacy on Social Media
Social media’s ability to unify populations despite distance has come to be a key ...
Engaging Oncology Scientific Leaders to Drive Commercial Success
The oncology market is growing in both size and complexity, driven by new immunotherapy ...
